Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022

SELL
$42.05 - $47.77 $46,843 - $53,215
-1,114 Reduced 9.19%
11,014 $479,000
Q1 2022

May 05, 2022

SELL
$40.23 - $47.74 $3,580 - $4,248
-89 Reduced 0.73%
12,128 $528,000
Q4 2021

Feb 11, 2022

BUY
$38.88 - $45.31 $7,192 - $8,382
185 Added 1.54%
12,217 $538,000
Q1 2021

May 13, 2021

SELL
$34.27 - $40.01 $179,266 - $209,292
-5,231 Reduced 30.3%
12,032 $429,000
Q4 2020

Feb 09, 2021

SELL
$34.07 - $39.94 $113,214 - $132,720
-3,323 Reduced 16.14%
17,263 $635,000
Q3 2020

Oct 22, 2020

BUY
$38.11 - $42.99 $64,825 - $73,125
1,701 Added 9.01%
20,586 $775,000
Q2 2020

Jul 06, 2020

BUY
$37.87 - $43.58 $89,789 - $103,328
2,371 Added 14.36%
18,885 $770,000
Q1 2020

Apr 27, 2020

SELL
$32.47 - $48.83 $479,516 - $721,121
-14,768 Reduced 47.21%
16,514 $626,000
Q4 2019

Jan 13, 2020

BUY
$42.0 - $48.25 $29,946 - $34,402
713 Added 2.33%
31,282 $1.47 Million
Q3 2019

Oct 11, 2019

BUY
$40.46 - $43.52 $12,987 - $13,969
321 Added 1.06%
30,569 $1.31 Million
Q2 2019

Jul 30, 2019

BUY
$39.4 - $42.7 $23,246 - $25,193
590 Added 1.99%
30,248 $1.21 Million
Q1 2019

Apr 12, 2019

BUY
$38.57 - $42.69 $36,294 - $40,171
941 Added 3.28%
29,658 $1.24 Million
Q4 2018

Feb 12, 2019

BUY
$37.8 - $42.69 $756,756 - $854,653
20,020 Added 230.19%
28,717 $1.1 Million
Q3 2018

Nov 16, 2018

BUY
$39.75 - $42.69 $76,836 - $82,519
1,933 Added 28.58%
8,697 $349,000
Q2 2018

Aug 14, 2018

SELL
$39.61 - $42.76 $71,852 - $77,566
-1,814 Reduced 21.15%
6,764 $272,000
Q1 2018

May 11, 2018

BUY
$36.18 - $40.15 $36,071 - $40,029
997 Added 13.15%
8,578 $335,000
Q4 2017

Mar 13, 2018

BUY
$35.34 - $41.9 $267,912 - $317,643
7,581
7,581 $268,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $68.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Omni Star Financial Group, Inc. Portfolio

Follow Omni Star Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Omni Star Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Omni Star Financial Group, Inc. with notifications on news.